Using siRNA, we investigated the effects of SLC25A43 knockdown (KD) on drug cytotoxicity in immortalised mammary epithelial cells, HER2-negative, and HER2-positive breast cancer cells after exposure to different drugs. Here, ERBB2 is linked to breast cancer.